Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation

Long-term safety of aromatase inhibitors in the treatment of breast cancer

(2016) J M Nabholtz   Therapeutics and Clinical Risk Management

Airway Responsiveness in Mild to Moderate Childhood Asthma

(2008) Kelan G. Tantisira et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer

(2008) Teresa Golden et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

(2008) Bruce D Keith   BMC CANCER

Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells

(2008) Ji Young Im et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Aromatase Inhibitors for Breast Cancer: Proven Efficacy Across the Spectrum of Disease

(2008) Christina I. Herold et al.   Clinical Breast Cancer

Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression

(2008) Weiwei Chen et al.   MOLECULAR ENDOCRINOLOGY

The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression

(2008) V BOONYARATANAKORNKIT et al.   STEROIDS

The Role of Selective Estrogen Receptor Modulators on Breast Cancer: From Tamoxifen to Raloxifene

(2008) Wen-Ling Lee et al.   Taiwanese Journal of Obstetrics & Gynecology

Protein phosphatase 5

(2007) Terry D. Hinds Jr. et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY